<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>The Lasker Foundation Economic Issues in Medical Research</title>
<link>http://www.laskerfoundation.org/newsite/advocacy/laskerrss.xml</link>
<description>Economic Issues in Medical Research</description>
<language>en-us</language>

<item>
<title>Reinventing Guantanamo: From detainee facility to center for research on neglected diseases of poverty in the Americas</title>
<link>http://www.plosntds.org/article/fetchArticle.action?articleURI=info:doi/10.1371/journal.pntd.0000201</link>
<description>SAN FRANCISCO: Reports that the Bush administration has expressed an interest in closing the Guantanamo Bay detainee facility in Cuba [1], colloquially known in the US as "Gitmo," could stimulate a new chapter in US foreign policy.</description>
</item>

<item>
<title>Drug ads to get more FDA scrutiny</title>
<link>http://www.usatoday.com/money/industries/health/drugs/2008-02-24-drug-ads_N.htm</link>
<description>WASHINGTON, DC: The Food and Drug Administration's current budget for reviewing consumer drug advertisements is larger than in the previous five years combined.</description>
</item>

<item>
<title>Bottom line for (Red)</title>
<link>http://www.nytimes.com/2008/02/06/business/06red.html?scp=3&amp;sq=medical+research+funding&amp;st=nyt</link>
<description>KIGALI, RWANDA: Just over a year ago, the rock star Bono started Red, a campaign that combined consumerism and altruism. Since then, consumers have generated more than $22 million to fight H.I.V. and AIDS in Rwanda by buying iPods, T-shirts, watches, cologne and most recently -- as anyone who watched the Super Bowl knows -- laptops, with all of them branded "(Product)RED."</description>
</item>

<item>
<title>Neglected diseases get research funding boost</title>
<link>http://www.scidev.net/gateways/index.cfm?fuseaction=readitem&amp;rgwid=4&amp;item=News&amp;itemid=4227&amp;language=1</link>
<description>LONDON: A group of European foundations have launched a new initiative to improve research into neglected tropical diseases in Africa.</description>
</item>

<item>
<title>Devil in the details</title>
<link>http://www.nature.com/nm/journal/v14/n2/full/nm0208-105.html</link>
<description>LONDON: The Innovative Medicines Initiative is an ambitious plan to accelerate the development of new drugs in the European Union. But however worthy, its implementation might prove challenging.</description>
</item>

<item>
<title>Charity to boost medical research with &#163;4bn</title>
<link>http://education.guardian.co.uk/higher/research/story/0,,2252769,00.html</link>
<description>LONDON: The UK's largest medical research funder, the Wellcome Trust, has today announced it will increase its funding to &#163;4bn over the next five years in what is believed to be the largest charitable spend in the UK.</description>
</item>

<item>
<title>Can world prize competitions foster more equitable drug research and development?</title>
<link>http://www.eurekalert.org/pub_releases/2008-02/unu-cwp020108.php</link>
<description>MAASTRICHT: Challenging researchers through international prize competitions to come up with innovative medicines and ideas for improving global health can help break existing profit-driven patterns that produce mostly drugs for the rich, according to world experts attending a landmark meeting devoted to the topic.</description>
</item>

<item>
<title>BioCentury and Nature Publishing Group announce inaugural issue of SciBX: Science-Business eXchange</title>
<link>http://www.scibx.com/scibx/pr080204.pdf</link>
<description>SAN CARLOS, CA: Nature Publishing Group (NPG) and BioCentury Publications Inc., today announced the inaugural edition of SciBX: Science-Business exchange, a highly anticipated weekly publication that identifies and evaluates developments in science and technology that have commercial and investment potential within the biotechnology and pharmaceutical arena.</description>
</item>

<item>
<title>U.S. funding shortfalls threaten science research</title>
<link>http://www.sciam.com/article.cfm?id=us-funding-shortfalls-thr</link>
<description>CHICAGO (Reuters) - Scientists are chafing at the U.S. government's unfulfilled pledge to boost funding for basic scientific research, the source of innovations ranging from the World Wide Web to high-tech cancer treatments.</description>
</item>

<item>
<title>A new manifesto for medical research In Europe</title>
<link>http://www.medicalnewstoday.com/articles/90959.php</link>
<description>Public spending on medical research in Europe should be doubled over the next ten years to ensure the health and welfare of Europe's citizens and to nurture a thriving medical research industry, according to an influential panel of distinguished scientists.</description>
</item>

<item>
<title>European Medical Research Councils (EMRC) White Paper: Present Status and Future Strategy for Medical Research in Europe</title>
<link>http://www.esf.org/nc/research-areas/medical-sciences/activities/emrc-white-paper/print.html</link>
<description>STRASBOURG: Public spending on medical research in Europe should be doubled over the next ten years to ensure health and welfare for Europe's citizens and to nurture a thriving European medical research industry.</description>
</item>

<item>
<title>Smoking will kill 1 billion people</title>
<link>http://www.time.com/time/health/article/0,8599,1711154,00.html</link>
<description>NEW YORK: One billion people will die from tobacco-related causes by the end of the century if current consumption trends continue, according to a global report released Thursday by the World Health Organization (WHO).</description>
</item>

<item>
<title>Growth of genetic tests concerns federal panel</title>
<link>http://www.nytimes.com/2008/01/18/us/18tests.html?_r=1&amp;oref=slogin</link>
<description>WASHINGTON: The science of genetic tests is marching ahead and so are efforts to sell them directly to consumers who are willing to send in a check and a bit of saliva to learn whether they are at risk for a disease.</description>
</item>

<item>
<title>Economic impact by state</title>
<link>http://www.researchamerica.org/state_econ</link>
<description>WASHINGTON, DC: Health research conducted in each state strengthens the local economies. This resource contains profiles of each state including the sources of investment in research, statistics for health-related industries, and highlights from local economic impact studies.</description>
</item>

<item>
<title>Potocnik calls on member states to work together on cancer research</title>
<link>http://cordis.europa.eu/fetch?CALLER=EN_NEWS&amp;ACTION=D&amp;SESSION=&amp;RCN=28705</link>
<description>BRUSSELS: EU Science and Research Commissioner Janez Potocnik has called on the EU's Member States to work more closely together on research to combat cancer.</description>
</item>

<item>
<title>The anatomy of medical school patenting</title>
<link>http://content.nejm.org/cgi/content/short/357/20/2049</link>
<description>BOSTON: Although issues related to patenting by faculty at academic medical centers have been the source of much controversy, there is little systematic evidence of the growth of these activities, their distribution among academic departments, and their relationship to faculty research efforts.</description>
</item>

<item>
<title>Aging population affects health costs only modestly</title>
<link>http://content.healthaffairs.org/cgi/content/abstract/hlthaff.27.1.w1</link>
<description>WASHINGTON, DC: Between 1987 and 2004, seniors spent far more per person than children or working-age adults, but the relative gap between the age groups has not changed much since 1987 except for those age eighty-five and older. </description>
</item>

<item>
<title>New resource highlights the burden of age-related eye disease and underscores the value of innovation</title>
<link>http://www.agingresearch.org/content/article/detail/1480</link>
<description>WASHINGTON, DC: The Alliance for Aging Research, in partnership with the National Alliance for Eye and Vision Research (NAEVR), released a new volume of The Silver Book&#174;: Chronic Disease and Medical Innovation in an Aging Nation dedicated to age-related eye disease--The Silver Book&#174;: Vision Loss.</description>
</item>

<item>
<title>Implications Of Expanding Disease Definitions: The Case Of Osteoporosis</title>
<link>http://content.healthaffairs.org/cgi/content/abstract/26/6/1702</link>
<description>BETHESDA: The National Osteoporosis Foundation and American College of Obstetrics-Gynecology have expanded osteoporosis therapy recommendations by changing the treatment threshold. We determined the impact of this recommendation using nationally representative U.S. data.</description>
</item>

<item>
<title>America's Health Care Safety Net: Revisiting The 2000 IOM Report</title>
<link>http://content.healthaffairs.org/cgi/content/abstract/26/5/1490</link>
<description>BETHESDA: The committee that wrote the 2000 Institute of Medicine report on the health care safety net reconvened in 2006 to reflect on the safety net from the perspective of rising numbers of uninsured and underinsured people, the aftermath of Hurricane Katrina, high immigration levels, and new fiscal and policy pressures on care for vulnerable populations.</description>
</item>

<item>
<title>FDA's Scrutiny Of Drug Makers Abroad Faulted</title>
<link>http://online.wsj.com/article/SB119393923740679324.html?mod=health_home_stories</link>
<description>WASHINGTON, DC: The Food and Drug Administration only has inspection records for about one-third of the foreign manufacturers that may be making drugs for U.S. consumers, congressional investigators found.</description>
</item>

<item>
<title>Privacy Concerns About Genetic Information May Increase Insurance Rates</title>
<link>http://www.blackwellpublishing.com/press/pressitem.asp?ref=1492</link>
<description>ONTARIO, CANADA: A new study published in The Journal of Risk &amp; Insurance explores the financial implications of banning insurance companies from accessing genetic information.</description> 
</item>

<item>
<title>Patents, Biomedical Research, and Treatment: Examining Concerns, Canvassing Solutions</title>
<link>http://www.thehastingscenter.org/patents-biomedical-research-treatment.asp</link>
<description>GARRISON, NY: Are biomedical patents inappropriate, ineffective, or even harmful to innovation and access, or are they vital to achieving these goals?  A new special report from The Hastings Center examines the debates.</description>
</item>


<item>
<title>Implications Of Expanding Disease Definitions: The Case Of Osteoporosis</title>
<link>http://content.healthaffairs.org/cgi/content/abstract/26/6/1702</link>
<description>BETHESDA: The National Osteoporosis Foundation and American College of Obstetrics-Gynecology have expanded osteoporosis therapy recommendations by changing the treatment threshold. We determined the impact of this recommendation using nationally representative U.S. data.</description> 
</item>


</channel>
</rss>






